Aethlon Medical Inc cash flow statement

In fiscal 2024, Aethlon Medical Inc's operations generated −$10.1m of cash; it spent $250,867 on capital projects, leaving free cash flow of −$10.4m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Aethlon Medical Inc: cash flow statement, annual
Fiscal year	2012Mar 2012	2013Mar 2013	2014Mar 2014	2015Mar 2015	2016Mar 2016	2017Mar 2017	2018Mar 2018	2019Mar 2019	2020Mar 2020	2021Mar 2021	2022Mar 2022	2023Mar 2023	2024Mar 2024
Cash from operations	−2	−2	−2	−5	−4	−4	−4	−4	−5	−7	−10	−11	−10
Depreciation and amortisation	0	0	0	0	0	0	0	0	0	0	0	0	0
Stock-based pay	1	1	1	0	0	2	1	1	1	1	1	1	1
Capital spending	0	0	0	0	0	0	0	0	0	0	0	1	0
Free cash flow	−2	−2	−2	−5	−4	−4	−4	−4	−5	−7	−10	−11	−10
Free cash flow after stock pay	−3	−3	−3	−5	−5	−6	−5	−6	−6	−8	−11	−13	−12
Share buybacks	—	—	—	—	0	0	0	0	—	—	—	—	—
Shares issued	0	2	3	5	6	3	10	1	12	7	17	9	1

US$ millions unless shown otherwise. Fiscal quarters.

Aethlon Medical Inc: cash flow statement, quarterly
Quarter	2022 Q1Jun 2021	2022 Q2Sept 2021	2022 Q3Dec 2021	2022 Q4Mar 2022	2023 Q1Jun 2022	2023 Q2Sept 2022	2023 Q3Dec 2022	2023 Q4Mar 2023
Cash from operations	−2	−2	−3	−3	−3	−3	−2	−3
Depreciation and amortisation	0	0	0	0	0	0	0	0
Stock-based pay	0	0	0	0	0	0	0	0
Capital spending	0	0	0	0	0	1	0	0
Free cash flow	−2	−2	−3	−3	−3	−4	−2	−3
Free cash flow after stock pay	−2	−2	−3	−4	−3	−4	−2	−3
Shares issued	17	0	0	0	1	8	0	0

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Aethlon Medical Inc's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Aethlon Medical Inc.